Source: Circulation. Unidade: ICB
Assunto: IMUNOLOGIA
ABNT
KETELHUTH, Daniel F. J. et al. Identification of a danger-associated peptide from apolipoprotein B100 (ApoBDS-1) that triggers innate proatherogenic responses. Circulation, v. 124, n. 22, p. 2433-2443 supl. 1-7, 2011Tradução . . Acesso em: 10 nov. 2024.APA
Ketelhuth, D. F. J., Rios, F. J. O., Wang, Y., Liu, H., Johansson, M. E., Fredrikson, G. N., et al. (2011). Identification of a danger-associated peptide from apolipoprotein B100 (ApoBDS-1) that triggers innate proatherogenic responses. Circulation, 124( 22), 2433-2443 supl. 1-7.NLM
Ketelhuth DFJ, Rios FJO, Wang Y, Liu H, Johansson ME, Fredrikson GN, Hedin U, Gidlund MA, Nilsson J, Hansson GK, Yan Z-qun. Identification of a danger-associated peptide from apolipoprotein B100 (ApoBDS-1) that triggers innate proatherogenic responses. Circulation. 2011 ; 124( 22): 2433-2443 supl. 1-7.[citado 2024 nov. 10 ]Vancouver
Ketelhuth DFJ, Rios FJO, Wang Y, Liu H, Johansson ME, Fredrikson GN, Hedin U, Gidlund MA, Nilsson J, Hansson GK, Yan Z-qun. Identification of a danger-associated peptide from apolipoprotein B100 (ApoBDS-1) that triggers innate proatherogenic responses. Circulation. 2011 ; 124( 22): 2433-2443 supl. 1-7.[citado 2024 nov. 10 ]